Predictors of hypertension among diabetic patients in the Ejisu municipality of Ghana

Florence Brenyah; Charles Apprey; Jacob K. Agbenorhevi; Felix C. Mills-Robertson

doi:10.12688/f1000research.146555.1

Home Browse Predictors of hypertension among diabetic patients in the Ejisu municipality...

ALL Metrics

-

Views

-

Downloads

Get PDF

Get XML

Export

▬

✚

Research Article

Predictors of hypertension among diabetic patients in the Ejisu municipality of Ghana

[version 1; peer review: 1 approved with reservations]

Florence Brenyah ¹, Charles Apprey¹, Jacob K. Agbenorhevi², Felix C. Mills-Robertson¹

PUBLISHED 21 Mar 2024

Author details Author details

¹ Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, +233, Ghana
² Department of Food Science and Technology, Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, +233, Ghana

Florence Brenyah
Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation

Charles Apprey
Roles: Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing

Jacob K. Agbenorhevi
Roles: Resources, Supervision, Writing – Review & Editing

Felix C. Mills-Robertson
Roles: Resources, Supervision, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

This article is included in the Global Public Health gateway.

Abstract

Introduction

The co-existence of hypertension with diabetes mellitus among diabetic patients is a setback to public health. About 40-75% of diabetic patients present with hypertension. The co-existence of hypertension and diabetes can accelerate complications such as stroke, myocardial infarction, nephropathy, and mortality. Available data indicate the devastating effects of hypertension and diabetes on individuals, families, and the economy as catastrophic. Therefore, knowing the predictors of hypertension among diabetic patients would inform the lifestyle and management of the two conditions.

Objective

The study focused on predictors of hypertension among diabetic patients in the Ejisu Municipality of Ghana.

Methods

The study employed a quantitative approach with a sample size of 120. Data were collected on sociodemographic characteristics, family history, 24-hour dietary recall, blood pressure, fasting blood glucose, glycated haemoglobin, total lipid profile, and anthropometrics. Data were analyzed using SPSS version 27.

Results

Out of 120 respondents, 85% were females with 77.5% above 50 years of age. A majority (66.7%) had a family history of diabetes with 76.7% having hypertension as a comorbidity. Fasting blood glucose was found to be 8.519 times more likely to present with hypertension. Systolic blood pressure, carbohydrate, and sodium intakes were 6.1%, 2.9%, and 0.1% respectively. However, diabetic patients with high HbA1c were 97% less likely not to present with hypertension.

Conclusion

Hypertension was found to be the most common comorbidity among diabetic patients in Ghana. Glycaemic control, systolic blood pressure, and dietary factors specifically carbohydrate and sodium intake were significant predictors of hypertension among the study participants.

Keywords

Predictors, Hypertension, Diabetic Patients, Ejisu Municipality, Ghana

Corresponding author: Florence Brenyah

Competing interests: No competing interests were disclosed.

Grant information: Kwame Nkrumah University of Science and Technology, Research Fund (KRef), Kumasi-Ghana. Grant reference number-VC/OGR/15.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright: © 2024 Brenyah F et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Brenyah F, Apprey C, K. Agbenorhevi J and C. Mills-Robertson F. Predictors of hypertension among diabetic patients in the Ejisu municipality of Ghana [version 1; peer review: 1 approved with reservations]. F1000Research 2024, 13:202 (https://doi.org/10.12688/f1000research.146555.1) First published: 21 Mar 2024, 13:202 (https://doi.org/10.12688/f1000research.146555.1) Latest published: 21 Mar 2024, 13:202 (https://doi.org/10.12688/f1000research.146555.1)

Introduction

Diabetes is acknowledged as one of the major causes of morbidity, disability and death.¹^–³ Globally, an estimated 1.13 billion and 463 million people are affected with hypertension and diabetes respectively. The implication is that 1 in every 11 adults aged between 20-79 years is affected by one or both health conditions.⁴ The more serious development is the emergence of hypertension among diabetic patients. Most discussions on diabetes and hypertension have centered on their common risk factors (physical inactivity, unhealthy dietary behaviour, excessive smoking, and alcohol consumption), the magnitude of people involved, and the management of both conditions.⁴^,⁵ The combined effects of the occurrence of these two health conditions have serious implications for individuals’ well-being and state welfare.⁶ Studies have shown that not only is the high incidence and complications associated with the co-existence of hypertension and diabetes in patients is significantly straining the healthcare system and providing a challenge to treatment but also largely associated with increased healthcare costs and plunging families into poverty.⁶^–⁸ For instance in low-resourced countries, the co-existence of hypertension and diabetes exacerbates the already fragile healthcare system, aggravates the plight of people with low socioeconomic status, and has a double burden on the government healthcare budget and gross domestic product.⁹^–¹³ This may have serious repercussions for quality of life, worsen life expectancy, and distort government budget allocations for development. Moreover, the devastating effects of hypertension and diabetes may thwart the World Health Organization’s (WHO) goal of decreasing 1/3 of morbidity and mortality rates from non-communicable diseases (NCDs) by 2030. ⁵^,¹⁴ The achievement of the content of the Global NCD Compact 2020-2030 which aims at preventing and controlling NCDs dwells on member states adopting policies and programmes that improve NCDs outcomes and save the lives of people living with NCDs. The 2020-2030 Global NCDs Agenda’s success may centre on human resources implicated in the surging NCDs occurrence.

In sub-Saharan Africa, some studies have been done separately on hypertension and diabetes among patients and community members in urban settings.¹⁵^–²¹ Studies of hypertension among diabetic patients in peri-urban communities are scanty. This study seeks to identify predictors of hypertension among diabetic patients in the Ejisu Municipality of Ghana.

In Ghana, hypertension and diabetes have continuously been among the top 10 causes of morbidity, hospital admissions, and mortality²²^–²⁴ in both urban and rural areas yearly. ²⁵^–³¹ These rankings are based on hospital-based data though it is known that most hypertension and diabetes cases are cared for at faith-based and herbal medicine centres and these are largely unreported cases. Again, a section of the population may not be aware of the existence of hypertension or diabetes as their health condition. Also, other people ignore they have the disease as reported by WHO and the International Diabetes Federation.⁴

Geographically, the occurrence of hypertension and diabetes just like any other health condition may be in segments based on the contents of the social gradient of health. The implication is that the degree of occurrence of hypertension and diabetes is affected by geographical variability due to differences in dietary behaviour, occupational status, socio-cultural factors, environmental influences, health seeking behaviour among others. The Ejisu Municipality is characterized as a diabetes-endemic zone with a high incidence of diabetes.³²^–³⁵ Studies have mentioned that 40-75% of diabetic patients present with hypertension and this significantly increases the development of diabetes-related complications and mortality.³⁶^,³⁷ Also, studies have reported that knowledge of conditions surrounding the occurrence of health conditions such as diabetes and hypertension may facilitate individual’s efforts in self-management of their health.³⁸ This is especially essential due to the possible differences in the prevalence, knowledge, treatment, and management of hypertension and diabetes globally and regionally. Therefore identifying the predictors of hypertension among diabetic patients in the municipality would provide evidence-based information for health stakeholders to develop appropriate mitigation mechanisms. Again, the outcome of this study may also serve as baseline data to guide the conduct of many research works on hypertension and diabetes.

Methods

Study setting

The study was conducted in the Ejisu and the Onwe Government Hospitals from March 2022 to July 2022.

Study type and approach

The current study adhered to STROBE checklist for study reporting. We therefor adopted a baseline cross-sectional study design with quantitative approach.

Study population

The study population covered all type II diabetic patients attending the diabetic clinic in the two hospitals in Ejisu Municipality.

Sample selection technique

The study adopted simple probability technology to recruit respondents (YES or NO) based on the folded paper. Participants who selected YES were considered for the study and were further taking through informed consent processes.

Inclusion and exclusion criteria

Inclusion and exclusion criteria were developed. The inclusion was participants above 18 years of age, diagnosed with diabetes <10 years, and void of any diabetes-related complications. All other patients aside from the above were excluded from the study.

Sample size determination

To achieve an 80% power to detect a 1% difference in HbAlc, the sample size was σ determined using the expression adopted by Noordij et al.³⁹ The equation is presented as:

n = \frac{2 [{(a + b)}^{2} \times σ^{2}]}{{(μ_{1} - μ_{2})}^{2}}

Where n is the sample size, $μ_{1}$ refers to the population mean in the interval group (HbAlc = 9.9) $μ_{2}$ is the population means in the control group (HbAlc = 8.9,) and represents the difference the investigator seeks to detect. The power of the test was set at 99% and at 5% significance where a = 1.96 for alpha (0.05) and b = 0.842 for power 0.80 and beta (0.20).

n = \frac{2 [{(2.579 + 0.842)}^{2} \times {1.6}^{2}]}{{(9.9 - 8.9)}^{2}} = 59.82

The sample size (n = 59.82) was approximated to be 60 participants for each hospital making 120.

Data collection tools and administration

Questionnaires made up of socio-demographic characteristics, 24-hour dietary recall, and anthropometric and blood pressure measurements were administered to patients. Again, the study also took the biochemical parameters of the participants.

Study variables

Anthropometric parameters

Height and body weight were measured using a stadiometer and a standard digital scale (Hewer brand, manufactured by G.S.T Corporation, New Delhi, India). The impedance of the body of each patient was calculated using Bioelectrical Impedance Analysis (BIA) by imputing the age, gender, and height. The patient was asked to stretch the arms parallel to the floor at shoulder level. The BIA consequently generates visceral fat (VF), muscle mass, body fat, and body mass index which were used as the standard references for the study

Dietary assessment procedure using 24-hour dietary recall

The triple-pass method was adapted for the 24-hour dietary recall.⁴⁰ The respondents had to mention the time at which the food or drink was consumed, a full description of the food or drink, including brand names where available, quantity consumed, based on household measures and food modules, foods eaten in combination, and any leftovers.

Blood pressure measurement

Each participant’s blood pressure was measured three times and the average was recorded using an automated sphygmomanometer (Intelli Sensetm boots blood pressure monitor) at the upper arm; recording the systolic and diastolic measurements. This was done after the participant had been allowed to rest for 15 minutes on arrival.

Biochemical parameters

A venous blood (5 mL) was drawn from the patients between 7 am and 9 am each day after an overnight fast according to the protocol declaration of Helsinki. Between these hours, 2 mL and 3 mL of the drawn blood were transferred carefully into separate tubes containing sodium fluoride and a gel-clot activator. Plasma was obtained from each participant’s blood sample for further analysis of plasma glucose concentration after allowing the samples in the sodium fluoride tubes to stand for about 2 hours. The blood samples in the gel-clot activator tubes were centrifuged at 3000 rpm for 10 minutes to obtain serum for each sample for further biochemical analysis.

Data management

Data were cleaned and entered into an IBM statistical package for social science (IBM SPSS) version 20. Data were stored electronically and secured with a password. Data would be discarded 3 years after the publication of this paper.⁴¹

Data analysis

Data from the anthropometric measurement was analysed into body mass index (BMI). The BMI was calculated as weight divided by square height (kg/m²) and categorised into (underweight <18.5, normal weight >18.5 <25, overweight < 25 >29.9 and Obese (≥ 30). The blood pressure was also categorized as normal (systolic 90-120 mmHg, diastolic 60-80 mmHg), pre-hypertension (systolic 120-140 mmHg, diastolic 80-90 mmHg) and hypertension (systolic 140-190 mmHg, diastolic 90-100 mmHg). The 24-hour dietary recall data were entered into the Nutritional Analysis Template. Appropriate commands were employed on the Nutritional Analysis Template to generate the results.

In analysing the blood samples, the concentration of each participant’s plasma glucose, total cholesterol, and HDL-cholesterol was measured via the use of the glucose oxidase-peroxidase method (GOD-POD method) whereas blood triglyceride and glycated haemoglobin (HbAlc) were measured using the Fortress Diagnostic Reagents and the CLOVER Alc^® Self Analyzer, respectively. Also, LDL-cholesterol level was calculated using the Friedwald Equation.⁴² The analysed data were presented as Tables in frequencies and percentages with statistical interpretations.

Results

Socio-demographic characteristics of participants

A majority (85%) of the participants were females. Over 77.5% of the participants were more than 50 years of age. It was found that 44.2% of participants were married, and 55.8% had Junior High/Middle School leaving certificates as their highest level of education as shown in Table 1.

Table 1. Socio-demographic characteristics of participants.

Variables	Frequency	Percentage
Gender
Male	18	15
Female	102	85
Age
Less than 31	1	0.8
31-40	5	4.2
41-50	21	17.5
50+	93	77.5
Ethnicity
Akan	111	92.5
Ewe	5	4.2
Northerner	4	3.3
Marital Status
Single	10	8.3
Married	53	44.2
Divorced	20	16.7
Widowed	37	30.8
Educational Level
None	23	19.2
Primary	18	15
MSLC/JHS	67	55.8
SHS	4	3.3
Tertiary	8	6.7
Religious Affiliation
Christianity	114	95.0
Muslim	5	4.2
Traditionalist	1	0.8
Employment Status
Self-employed	72	60.0
Employed (Gov't)	7	5.8
Unemployed	41	34.2

Medical history of non-communicable diseases

The study examined the family and participants’ medical history. In total, 66.7% of the participants had a family history of diabetes. Again, 40% of the participants had lived with diabetes for more than 5 years. The study found that 76.7% of the participants had hypertension as a comorbidity. All the participants were on combined medication for diabetes and hypertension or diabetes alone as shown in Table 2.

Table 2. Family medical history of NCDs.

Variables	Frequency	Percentage
Do you have a diabetic relative?
Yes	80	66.7
No	40	33.3
If Yes, which family member?
Parent	28	23.3
Siblings	22	18.3
Grandparents	1	0.8
Uncle	4	3.3
Auntie	7	5.8
Other relatives	18	15
Not Applicable	40	33.3
Year with diabetes
Less than 1 year	25	20.8
2-5 years	47	39.2
5-10 years	48	40.0
Existence of other NCDs?
Yes	92	76.7
No	28	23.3
If Yes, specify
Hypertension	92	76.7
Stroke	0	0
Kidney Condition	0	0
None	28	23.3
Hypertension drugs used
Nifedipine	40	33.3
Nifedipine and Aspirin	3	2.5
Lisinopril	15	12.5
Amlodipine	25	20.8
Losartan	9	7.5
Not Applicable	28	23.3
Diabetic drugs used
Metformin	83	69.2
Glibenclamide	3	2.5
Metformin and Glibenclamide	33	27.5
Insulin	1	0.8

Anthropometrics and blood pressure parameters of respondents

The study found that 36.7% and 25.8% were overweight and obese respectively. Also, 42.5% of participants recorded elevated visceral fat while 90.1% recorded high body fat. Again, with systolic blood pressure, 35.8% and 49.5% recorded prehypertension and hypertension levels respectively while 33.3% and 45.5% recorded pre-hypertension and elevated blood pressure levels in the diastolic as presented in Table 3.

Table 3. Anthropometric and blood pressure parameters of respondents.

Parameter	Freq.	Percent
BMI (kg/m²)
Underweight (˂18.5)	2	1.7
Normal weight (18.5-25)	43	35.8
Overweight(25-29.9)	44	36.7
Obese (≥ 30)	31	25.8
VISCERAL FAT
Normal ≤ 9	69	57.5
High ≥ 10	51	42.5
BODY FAT (%)
Low ˂ 23	1	1.2
Normal 23-35.9	7	8.7
High ˃34	112	90.1
SYSTOLIC (mmHg)
Normal (90-120)	18	15
Pre-Hypertension (120-140)	43	35.8
Hypertension (140-190)	59	49.2
DYSTOLIC (mmHg)
Normal (60-80)	26	21.7
Pre-Hypertension( 80-90)	40	33.3
Hypertension (90-100)	54	45

Biochemical parameters of respondents

About 55.8% of the respondents have high fasting blood glucose levels. Also, 47.5% had elevated glycated levels. In measuring lipid profile, 62.5% and 37.5% of the respondents were within the normal range of high-density lipoprotein (HDL) and low HDL respectively. The majority of the respondents 82.5% were within the normal range of low-density lipoprotein. Again, 40.8% of participants were within the elevated range of total cholesterol while 40.8% of them recorded elevated triglyceride levels as shown in Table 4.

Table 4. Biochemical parameters of respondents.

Parameters	Frequency	Percent
FBS (mmol/l)
Normal (4-6)	53	44.2
High	67	55.8
HbA1c (%)
Normal level ( 4-7)	62	51.7
Elevated (7-9)	17	14.2
Severely elevated (˃9)	40	33.3
Low (˂4)	1	0.8
Total Cholesterol
Normal (˂5.2)	71	59.2
High (˃6.2)	49	40.8
Triglyceride
Normal (˂1.69)	69	57.5
High (˃1.69)	51	42.5
HDL
Low (˃1.55)	45	37.5
Normal ˂1.55)	75	62.5
LDL
Normal (˂1.88)	99	82.5
High (˃1.88)	21	17.5

Dietary intakes of respondents

The study found that 50.8% of participants met the RDA of caloric intake and 84.2% met the protein requirement. Almost all the participants (99.2%) met the RDA for carbohydrate intakes with 62.5% meeting the recommended intakes of dietary fiber. With the micro-nutrients, the overwhelming majority did not meet the RDA of calcium (99.2%) and potassium (88.3%). About (60.8%) and (36.7%) met the RDA of dietary sodium and zinc intakes respectively while the majority of the respondents (91.7%) met the recommended intakes of dietary copper as shown in Table 5.

Table 5. Dietary intakes of participants.

Dietary intake (RDA)	Frequency	Percent
KCAL MALES
Did not meet RDA	59	49.2
Met RDA	61	50.8
PROTEIN (46 g)
Did not meet RDA	19	15.8
Met RDA	101	84.2
CARBS (130 g)
Did not meet RDA	1	0.8
Met RDA	119	99.2
FIBRE (26 g)
Did not meet RDA	75	62.5
Met RDA	45	37.5
CALCIUM(1300 mg)
Did not meet RDA	119	99.2
Met RDA	1	0.8
POTASSIUM (4700 mg)
Did not meet RDA	106	88.3
Met RDA	14	11.7
SODIUM (2500 mg)
Did not meet RDA	47	39.2
Met RDA	73	60.8
ZINC (9 mg)
Did not meet RDA	76	63.3
Met RDA	44	36.7
COPPER (0.89 mg)
Did not meet RDA	10	8.3
Met RDA	110	91.7

Hypertension among diabetic patients

The model correctly predicted that 88 out of the 102 patients who reported hypertension had hypertension with an accuracy rate of about 96%. The accuracy level for a correct prediction of patients who did not report hypertension was 64%, predicting that 18 out of the 28 patients who reported without hypertension did not have hypertension. Overall, the model accurately predicted 88.3% of the observed results as shown in Table 6.

Table 6. Hypertension among diabetic patients.

Variable		Observed	Predicted
			Reporting with other NCDs		Percentage correct
			Hypertension	None
Step 1	Reporting with other NCDs	Hypertension	88	4	95.7
Step 1	Reporting with other NCDs	None	10	18	64.3
	Overall Percentage				88.3

Predictors of hypertension among diabetic patients

From Table 7, DM patients who had high HbA1c were less likely to report to the hospital with hypertension the odds of 0.028. The results also showed that, as the fasting blood glucose (FBG) of the diabetic patients increased, they were 8.519 times or 751.9% more likely to present with hypertension. The diabetic patients with high systolic blood pressure also had 6.1% odds of presenting with hypertension with every one unit increase in systolic blood pressure. As the intake of carbohydrates increases, there is a decreasing odd (2.9%) of diabetic patients presenting with hypertension. The results also indicated that increasing the intake of sodium by diabetic patients increases (0.1%) the odds of presenting with hypertension.

Table 7. Predictors of hypertension among diabetic patients.

Predictor variables	B	Sig.	Odds ratio
HbA1c	-3.575	.003	0.028
FBG	2.142	.004	8.519
Systolic	0.059	.029	1.061
Carbohydrates(g)	-0.029	.011	0.971
Sodium (mg)	0.001	.017	1.001

Discussion

In this section, we discussed the results of this study in comparison with other studies conducted and published by various authors on the subject matter. Our discussion is also patterned along sociodemographic characteristics, medical history, biochemical, anthropometric, and blood pressure parameters, dietary intakes, and predictors of hypertension among diabetic patients.

The study found that female participants formed the majority group probably because studies have found more women than men visit clinics to seek health care.⁴³^,⁴⁴ The majority of the study participants were above 50 years and this is consistent with research outcomes reporting both diabetes and hypertension as associated with increasing age.⁴⁵^–⁴⁷ Emphasizing this, a study by Atibila et al.,⁴⁶ in the Dormaa Ahenkro Municipality in Ghana, reported that increasing age (≥ 45 years) was associated with a 2.75 increased odds of developing hypertension. Again, Bai et al.,⁴⁷ reported an increasing prevalence of diabetes as age increased. The current study found that the majority of the participants were married. This is consistent with other studies that reported on gender sensitivity in males and females regarding hypertension and diabetes occurrence.⁴⁸^,⁴⁹ For instance, the study of being married was an important risk factor for hypertension and tended to be a significant risk factor for mortality in men as reported by Ramezankhani, Azizi, & Hadaegh.⁴⁸ The implication is that the current study outcome of the association of marriage with hypertension and diabetes is in consonance based on females and contrary when men are considered as reported by Ramezankhani, Azizi, & Hadaegh.⁴⁸ Another study by Tuoyire & Ayetey⁴⁹ reported on the contrary that, married men had significantly higher odds of hypertension than females. Further study findings revealed by Ford & Robitaille⁵⁰ mentioned that married people had better HBA1C values than their single counterparts. In terms of educational status, the majority of the participants had a middle/secondary school certificate as their highest level of education. This is consistent with other studies’ results which have reported a higher percentage of type 2 diabetic patients had little education.⁵¹^,⁵² The implication is the likelihood of poor glycaemic control and poor blood pressure management which may be due to poor knowledge on hypertension and diabetes.

In the assessment of medical history, the majority of the study participants had a family history of diabetes and hypertension, and this finding is consistent with other research outcomes which report that a family history of diabetes and hypertension increases an individual’s risk of developing the condition.⁵³^–⁵⁶ Again, the current study found a high occurrence of the co-existence of hypertension and diabetes and this is consistent with the study by Haile et al.,³¹ and Berbari et al.⁵⁷

The anthropometric assessment revealed that more than half of our study participants were overweight and obese which has implications for the occurrence of hypertension and diabetes. This is in consonance with the study outcome of Patel, et al.,⁵⁸ which revealed that among their study participants, every standard deviation higher in BMI was associated with a 1.65 and 1.60 times higher probability of developing diabetes and 1.42 and 1.28 times higher probability of developing hypertension, for men and women respectively. This is similar to a study by Ofori-Asenso et al.,⁵⁹ which reported a greater prevalence of overweight and obesity in Ghana. Clearly, not only is obesity associated with hypertension and diabetes but also has strong links to the increase of visceral fat.⁵⁸ A little below half of the participants recorded high visceral fat and an overwhelming number of the participants recorded high body fat. This ties well with the assertion by Agyemang-Yeboah et al.⁶⁰ that excess amounts and distribution of body adiposity have been implicated in the development of cardio-metabolic diseases such as heart attack, stroke, insulin resistance, and non-alcoholic fatty diseases. For instance, evidence-based research by Strong, et al.,⁶¹ reports that a 10% increase in overweight and obesity causes an increment of 4% in diabetes and 4.9% in hypertension in India. Again, Strong et al.⁶¹ put forward that, 35.8% and 33.3% of participants recorded high systolic and diastolic blood pressure signifying pre-hypertension. Tan & Thakur,⁶² assert that studies have shown a J-curve association between blood pressure among diabetic patients and with risk of myocardial infarction and death. In corroborating the assertion of Tan & Thakur,⁶² the review of Gaffney, et al.⁶³ equally mentioned that a “J” or “U-shaped curve” in the association between diastolic BP and cardiovascular events has been observed in epidemiological studies, suggesting that both high diastolic BPs and low diastolic BPs below are associated with a higher risk of cardiovascular disease (CVD) events and these have the tendency of exacerbating the condition of diabetic patients. Petrie, Guzik, & Touyz,⁶⁴ gave confirmatory reports that several studies have linked poorly controlled high blood pressure among diabetic patients to higher increase in heart diseases, renal diseases, and stroke. Equally, a study outcome by John Hopkins University in 2023⁶⁵ revealed that high blood pressure is twice more likely to strike a person with diabetes than a person without diabetes. The study also emphasised that a person with diabetes and high blood pressure is four (4) times more likely to develop heart disease than someone who does not have either of the conditions.⁶⁵

The outcome of the biochemical analysis in our study revealed that more than half of the participants had their fasting blood glucose poorly controlled and 33.3% of the respondents had their haemoglobin A1C (HbA1c) poorly controlled. A study by Li, Xu, Liu, et al.⁶⁶ confirmed that Poor glycemic control (HbA1c ≥8%) has been associated with decreased survival in the general population of diabetic patients on maintenance hemodialysis among patients in China. Similarly, the study outcome of Cheneke, et al.⁶⁷ found that even though the study participants were on diabetes treatment, the majority of them were found to have poor glycemic control. Similar studies in the sub-Saharan Africa context by Govender, et al.,⁶⁸ and Legese, et al.,⁶⁹ have shown that poor fasting blood glucose and haemoglobin A1C status have been found among diabetic patients. Again, we found that 40.8% of the study participants in our research recorded high total cholesterol levels with a little below half recording high triglyceride levels above 1.71mmol/L. Also, a little below half of our study participants had low HDL levels and just (17.5%) recorded elevated LDL levels. Studies have found that healthy subjects without metabolic syndrome increasing triglyceride levels within the normal range can trigger a continuous increase in type 2 diabetes incidence.⁷⁰ Therefore proper management of dyslipidemia could help reduce the development of hypertension among diabetic patients and reduce hypertension-associated complications such as nephropathy.⁶⁷^,⁶⁹

Dietary behaviour is associated with the onset of hypertension and diabetes. Our study found that the majority of the respondents met the recommended dietary allowance (RDA) of protein and carbohydrates while about half of the respondents met the RDA of caloric intake. A Research outcome from the Chinese Centre for Disease Control and Prevention stated that the ratio of macronutrients to total dietary energy for diabetics is recommended to be: 15 to 20 % protein, 45% to 60% carbohydrate, and 20% to 35% fat. Our study participants are therefore commended for meeting that requirement. However, we found 37.5% of respondents did not meet the RDA of fibre which aids in the prevention and management of diabetes, reduction of cholesterol, protection of the heart as well as management of weight. Again, we found a majority of the respondents recorded inadequate intake of calcium, potassium, and zinc (micro-nutrients). These minerals are considered important in maintaining the homeostasis of glucose metabolism. Similarly, the study by Baqar, et al.⁷¹ revealed that only 7% and 5% of participants met dietary sodium and potassium requirements respectively.

In assessing the predictors of hypertension and diabetes, factors such as the level of HbA1c, FBS, systolic blood pressure, intakes of carbohydrates, and sodium were the main determinants in our study. For instance, our study results seem to suggest that, relating to glycemic control parameters, individuals with higher HbA1c were less likely to have hypertension, while increasing fasting blood glucose (FBG) values increased the likelihood of an individual having hypertension. Our finding is contrary to the results of Bower et al.,⁷² who reported that higher HbA1c was associated with an increased risk of hypertension. Differences in outcomes relating to HbA1c in our study and that of Bower et al.⁷² may be due to certain confounders of which we are not privy. Based on our study results, we share a similar opinion with operational research studies outcomes that have reported that poor glycaemic control increases one’s risk of developing diabetes-related complications, including hypertension in diabetic patients.¹⁸^,⁷³^,⁷⁴ Again, our study outcome revealed that, high systolic blood pressure was associated with an increase in the likelihood of hypertension. Studies have reported that systolic hypertension is more highly associated with cardiovascular events than diastolic hypertension.⁷⁵^,⁷⁶ In relating this finding to our study outcomes, we realized that barring all other confounders, our study participants may be at a higher risk of experiencing adverse cardiovascular events. Also, our study found that increased intake of carbohydrates was predictively associated with reduced odds of participants’ hypertension occurrence. This finding in our study is a bit complicated especially when we are aware that, a study by Wheatley et al.⁷⁷ has reported that carbohydrate restriction positively impacts glycaemic control in diabetic patients. Our study could not readily ascertain the reasons for the differences in outcomes. However, the study outcome of Bonsembiante et al.⁷⁸ and Li et al.⁷⁹ seem to offer an explanation that; a high carbohydrate diet relying on carbohydrates with a low glycaemic index and higher fibre content can be beneficial for diabetic patients, whereas rapidly digestible, high glycaemic index carbohydrates negatively impact glycaemic control in such patients and predispose them to complications like hypertension.

Finally, we found that increased intake of sodium by study participants increased their odds of presenting with hypertension. This is evidenced in published literature highlighting high sodium intakes and associated risks such as the development of hypertension.⁸⁰^–⁸² This is consistent with study outcomes which report high salt and processed food intake in sub-Saharan Africa.⁶³^,⁸³^,⁸⁴

Conclusion

The study found the prevalence of systolic and diastolic hypertension among diabetic patients to be 49.2% and 45.0% respectively. The study concludes that sociodemographic characteristics, family history, anthropometric variables, blood pressure and unhealthy dietary behaviour are key in the occurrence of hypertension among diabetic patients

Study limitation

The study is limited in scope mainly due to the fact that, participants were recruited from only two hospitals in the municipality. It would have been more appropriate to sample participants across minimum of two regions in Ghana thus making the results valid for generalization. Despite this limitation, the outcome of this study may give a baseline data for health researchers for further studies.

Recommendations

The study calls for preventive measures such as health promotion and education on the risk factors of hypertension and the repercussions on diabetes within the population in order to control the tide of the co-existence of hypertension and diabetes among patients.

Direction for future research

It is suggested that future research should cover the health-seeking behaviour and management of the co-existence of hypertension and diabetes in rural areas in Ghana.

Disclosure of ethical statements

Informed consent:

Informed consent was conducted with the patients. The study participants were approached face to face and the purpose of the study were explained to them. Those who consented to participate in the study were given written consent forms to sign and date in duplicates.

• Approval of the research protocol:
The KNUST Committee for Human Research, Publication, and Ethics approved the study by vetting thoroughly the content of the study proposal with approval number CHRPE/AP/168/22.

Data availability

Underlying data

Dryad: Predictors of hypertension among diabetic patients in the Ejisu Municipality of Ghana, https://doi.org/10.5281/zenodo.10431520.⁸⁵

This study contains the following files:

• Data on hypertension among diabetic patients. This data consist of all the parameters on hypertensive and diabetic patients who participated in this study from two hospitals name Hospital A and B.
• Questionnaire. This questionnaire covers the family and medical history, knowledge on diabetes, lifestyle practices, 24hour dietary recall, anthropometric measurements, and biochemical parameters.
• Raw Data on hypertension among diabetic patients (Baseline data). This dataset is in SPSS. To access this data, one needs to have SPSS installed on the computer.
• Coding Scheme: The data used the coding scheme below in the SPSS:
FBG - Fasting Blood Glucose
HDL - High-Density Lipoprotein
LDL - Low-Density Lipoprotein
TG - Triglyceride
VF - Visceral Fat

Extended data

• Analysed Dataset: This is the results of the analysed that uploaded as ‘supporting tables out of the study data’
• Participant information sheet: This document provided information about the nature and processes of the study for the participants to make informed decisions and confirm participation by signing consent form or otherwise.
• Consent forms: This sheet signed by participants meant they have willingly given their consent to participate in the study.

Data is available under the terms of the CC BY 4.0 Attribution 4.0 International. https://creativecommons.org/licenses/by/4.0/.

References

1. Magliano DJ, Boyko EJ: IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. 10th edition.Brussels: International Diabetes Federation; 2021. Reference Source
2. Kumar A, Gangwar R, Ahmad Zargar A, et al.: Prevalence of diabetes in India: A review of IDF Diabetes Atlas 10th edition. Curr. Diabetes Rev. 2023 Apr 13; 20: e130423215752. PubMed Abstract | Publisher Full Text
3. Afaya RA, Bam V, Azongo TB, et al.: Knowledge of chronic complications of diabetes among persons living with type 2 diabetes mellitus in northern Ghana. PLos One. 2020; 15(10): e0241424. PubMed Abstract | Publisher Full Text | Free Full Text
4. World Health Organization: Diabetes 2020.July 2020. Reference Source
5. Siddiqi K: Non-communicable diseases.Walley J, Wright J, editors. Public Health: An action guide to improving health. 2nd edn.Oxford: Oxford Academic; 2010. 2010. online edn. Publisher Full Text
6. Zabetian A, Keli HM, Echouffo-Tcheugui JB, et al.: Diabetes in the middle East and north Africa. Diabetes Res. Clin. Pract. 2013; 101(2): 106–122. Publisher Full Text
7. Mehta R, Mantri N, Goel AD, et al.: Out-of-pocket spending on hypertension and diabetes among patients reporting in a health -care teaching institute of the Western Rajasthan. J. Family Med. Prim. Care. 2022; 11(3): 1083–1088. PubMed Abstract | Publisher Full Text | Free Full Text
8. Kishindo M, Kamano J, Mwangi A, et al.: Are outpatient costs for hypertension and diabetes care affordable? Evidence from Western Kenya. African Journal of Primary Health Care & Family Medicine. 2023; 15(1): e1–e9. PubMed Abstract | Publisher Full Text | Free Full Text
9. Mohan V, Seedat YK, Pradeepa R: The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int. J. Hypertens. 2013; 2013: 409083. PubMed Abstract | Publisher Full Text | Free Full Text
10. Tareque MI, Koshio A, Tiedt AD, et al.: Are the Rates of Hypertension and Diabetes Higher in People from Lower Socioeconomic Status in Bangladesh? Results from a Nationally Representative Survey. PLoS ONE. 2015; 10(5): e0127954. PubMed Abstract | Publisher Full Text | Free Full Text
11. Yaya S, El-Khatib Z, Ahinkorah BO, et al.: Prevalence and Socioeconomic Factors of Diabetes and High Blood Pressure Among Women in Kenya: A Cross-Sectional Study. Journal of epidemiology and global health. 2021; 11(4): 397–404. Publisher Full Text
12. Choukem SP, Kengne AP, Dehayem YM, et al.: Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res. Clin. Pract. 2007; 77(2): 293–299. PubMed Abstract | Publisher Full Text
13. Emmerick ICM, Campos MR, da Silva RM , et al.: Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the “Farmácia popular” program in Brazil: an interrupted time series study. BMC Public Health. 2020; 20: 24. PubMed Abstract | Publisher Full Text | Free Full Text
14. Aroda VR, Knowler WC, Crandall JP, et al.: Metformin for diabetes prevention: insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017; 60(9): 1601–1611. PubMed Abstract | Publisher Full Text | Free Full Text
15. Gatimu SM, Milimo BW, Sebastian MS: Prevalence and determinants of diabetes among older adults in Ghana. BMC Public Health. 2016; 16(1): 1174. PubMed Abstract | Publisher Full Text | Free Full Text
16. Mirzaei M, Mirzaei M, Bagheri B, et al.: Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health. 2020; 20: 667. PubMed Abstract | Publisher Full Text | Free Full Text
17. Nshisso LD, Reese A, Gelaye B, et al.: Prevalence of hypertension and diabetes among Ethiopian adults. Diabetes & metabolic syndrome. 2012; 6(1): 36–41. PubMed Abstract | Publisher Full Text | Free Full Text
18. Mariye T, Girmay A, Tasew H, et al.: Determinants of hypertension among diabetic patients in Public Hospitals of the Central Zone, Tigray, Ethiopia 2018: unmatched case-control study. Pan Afr. Med. J. 2019; 33: 100. PubMed Abstract | Publisher Full Text | Free Full Text
19. Correia JC, Lachat S, Lagger G, et al.: Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review. BMC Public Health. 2019; 19: 1542. PubMed Abstract | Publisher Full Text | Free Full Text
20. Bossman IF, Dare S, Oduro BA, et al.: Patients’ knowledge of diabetes foot complications and self-management practices in Ghana: A phenomenological study. PloS one. 2021; 16(8): e0256417. PubMed Abstract | Publisher Full Text | Free Full Text
21. Owusu AY, Kushitor SB, Ofosu AA, et al.: Institutional mortality rate and cause of death at health facilities in Ghana between 2014 and 2018. PLoS ONE. 2021; 16(9): e0256515. PubMed Abstract | Publisher Full Text | Free Full Text
22. Narh CT, Der JB, Ofosu A, et al.: Trends in hospitalization of patients with diabetes mellitus in Ghana from 2012 to predictions to 2032. Int. Health. 2022; 14(6): 588–596. PubMed Abstract | Publisher Full Text | Free Full Text
23. Awumee V, Dery SK, K.: Continuity of care among diabetic patients in Accra, Ghana. Front. Public Health. 2023; 11: 1141080. PubMed Abstract | Publisher Full Text | Free Full Text
24. Animaw W, Seyoum Y: Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 2017; 12(11): e0187670. Publisher Full Text
25. Asamoah-Boaheng M, Sarfo-Kantanka O, Tuffour AB, et al.: Prevalence and risk factors for diabetes mellitus among adults in Ghana: a systematic review and meta-analysis. Int. Health. 2019; 11(2): 83–92. PubMed Abstract | Publisher Full Text
26. Katey D, Addo AA, Abass K, et al.: Prevalence study of type 2 diabetes mellitus in the Ashanti region of Ghana: a systematic review of risk factors. J. Endocrinol. Metab. Diabetes S. Afr. 2022; 27(3): 93–99. Publisher Full Text
27. Cook-Huynh M, Ansong D, Steckelberg RC, et al.: Prevalence of hypertension and diabetes mellitus in adults from a rural community in Ghana. Ethn. Dis. 2012; 22(3): 347–352. PubMed Abstract
28. Sarfo FS, Gyamfi RA, Adamu S, et al.: Administration of a pictorial questionnaire to screen for stroke among patients with hypertension or diabetes in rural Ghana. J. Neurol. Sci. 2017; 373: 289–294. PubMed Abstract | Publisher Full Text | Free Full Text
29. Opare-Addo MN, Buabeng KO, Marfo AF, et al.: Source of medicines and medicine information by self-reported persons living with hypertension and diabetes in rural and urban Ghana. Pharmacy Practice (Granada). 2022; 16(3): 1151. Publisher Full Text
30. Haile TG, Mariye T, Tadesse DB, et al.: Prevalence of hypertension among type 2 diabetes mellitus patients in Ethiopia: a systematic review and meta-analysis. Int. Health. 2022; 15: 235–241. PubMed Abstract | Publisher Full Text | Free Full Text
31. Ghana News Association: Hypertension and diabetes on the rise in Ejisu-Juaben.2011. Accessed January 7, 2023. Reference Source
32. Obour SK: Cases of hypertension, diabetes in Ejisu alarming.2013. Accessed January 7, 2023. Reference Source
33. Owusu-Ansah J: Factors influencing treatment outcomes of Patients with Diabetes and Hypertension at the Ejisu Government Hospital in Ejisu, Ashanti Region, Ghana. Dissertation.2020. Accessed January 3, 2023. Reference Source
34. Gatorwu S: Kidney Health International hold World Diabetes Day at Ejisu.2022. Accessed May 3, 2023. Reference Source
35. Akalu Y, Belsti Y: Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia. Diabetes, metabolic syndrome and obesity: targets and therapy. 2023; 13: 1621–1631. Publisher Full Text
36. Jelinek HF, Osman WM, Khandoker AH, et al.: Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from the United Arab Emirates. BMJ Open Diabetes Research &Amp; Care. 2017; 5(1): e000427. PubMed Abstract | Publisher Full Text | Free Full Text
37. Osei-Yeboah J, Owusu-Dabo E, Owiredu WKBA, et al.: Community burden of hypertension and treatment patterns: An in-depth age predictor analysis: (The Rural Community Risk of Non-Communicable Disease Study - Nyive Phase I). PLoS One. 2021; 16(8): e0252284. PubMed Abstract | Publisher Full Text | Free Full Text
38. Swed S, Alibrahim H, Bohsas H, et al.: Assessment the awareness toward hypertension and diabetes mellitus: Syrian cross sectional study. BMC Public Health. 2023; 23: 789. PubMed Abstract | Publisher Full Text | Free Full Text
39. Noordzij M, Tripepi G, Dekker FW, et al.: Samplesize calculations: basic principles and common pitfalls. Nephrol. Dial. Transplant. 2010; 25(5): 1388–1393. PubMed Abstract | Publisher Full Text
40. Nightingale H, Walsh KJ, Olupot-Olupot P, et al.: Validation of triple pass 24-hour dietary recall in Ugandan children by simultaneous weighed food assessment. BMC Nutr. 2016; 2: 56. Publisher Full Text
41. Institutional Review Board-University of Florida: Investigator requirement for retaining research data. Protecting the right and welfare of human research subjects.2021. Accessed on 4^th July, 2023. Reference Source
42. Krishnaveni P, Gowda VM: Assessing the Validity of Friedewald’s Formula and Anandraja’s Formula For Serum LDL-Cholesterol Calculation. J. Clin. Diagn. Res. 2015; 9(12): BC01–BC04. Publisher Full Text
43. Bertakis KD, Azari R, Helms LJ, et al.: Gender differences in the utilization of health care services. J. Fam. Pract. 2000. 49(2): 147–52. PubMed Abstract
44. Hunt K, Adamson J, Hewitt C, et al.: Do women consult more than men? A review of gender and consultation for back pain and headache. J. Health Serv. Res. Policy. 2011; 16(2): 108–117. PubMed Abstract | Publisher Full Text | Free Full Text
45. Zafari N, Asgari S, Lotfaliany M, et al.: Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up. Sci. Rep. 2017; 7(1): 14220. PubMed Abstract | Publisher Full Text | Free Full Text
46. Atibila F, Owusu-Dabo E, Asamani JA, et al.: Assessment of risk factors for hypertension in Dormaa municipality in Ghana using the World Health Organization STEPS approach. J. Health Sci. 2018; 8(3): 171–180. Publisher Full Text
47. Bai A, Tao J, Tao L, et al.: Prevalence and risk factors of diabetes among adults aged 45 years or older in China: A national cross-sectional study. Endocrinology, diabetes & metabolism. 2021; 4(3): e00265. PubMed Abstract | Publisher Full Text | Free Full Text
48. Ramezankhani A, Azizi F, Hadaegh F: Associations of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: A long-term follow-up study. PLoS One. 2019; 14(4): e0215593. PubMed Abstract | Publisher Full Text | Free Full Text
49. Tuoyire D, Ayetey H: Gender difference in the association between marital status and hypertension in Ghana. J. Biosoc. Sci. 2019; 51(3): 313–334. Publisher Full Text
50. Ford KJ, Robitaille A: How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing. BMJ Open Diabetes Research & Care. 2023; 11(1): e003080. PubMed Abstract | Publisher Full Text | Free Full Text
51. Tedesco MA, Di Salvo G, Caputo S, et al.: Educational level and hypertension: how socioeconomic differences condition health care. J. Hum. Hypertens. 2021; 15: 727–731. PubMed Abstract | Publisher Full Text
52. Sun K, Lin D, Li M, et al.: Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adults. J. Epidemiol. Community Health. 2022; 76: 451–457. PubMed Abstract | Publisher Full Text | Free Full Text
53. Cederberg H, Stančáková A, Kuusisto J, et al.: A family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage?. J. Intern. Med. 2015; 277(5): 540–551. PubMed Abstract | Publisher Full Text
54. Dosoo DK, Nyame S, Enuameh Y, et al.: Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study. Int. J. Hypertens. 2019; 2019: 1–7. Publisher Full Text
55. Li AL, Peng Q, Shao YQ, et al.: The interaction on hypertension between family history and diabetes and other risk factors. Sci. Rep. 2021; 11(1): 4716. PubMed Abstract | Publisher Full Text | Free Full Text
56. Berbari AE, Daouk NA, Nasr EM: Coexistence of Diabetes Mellitus and Hypertension.Berbari AE, Mancia G, editors. Blood Pressure Disorders in Diabetes Mellitus. Updates in Hypertension and Cardiovascular Protection. Cham: Springer; 2023. Publisher Full Text
57. Patel SA, Ali MK, Alam D, et al.: Obesity and its Relation with Diabetes and Hypertension: A Cross-Sectional Study Across 4 Geographical Regions. Glob. Heart. 2016; 11(1): 71–79.e4. PubMed Abstract | Publisher Full Text | Free Full Text
58. Ofori-Asenso R, Agyeman AA, Laar A, et al.: Overweight and obesity epidemic in Ghana-a systematic review and meta-analysis. BMC Public Health. 2016; 16(1): 1239. PubMed Abstract | Publisher Full Text | Free Full Text
59. Agyemang-Yeboah F, Eghan BAJ, Annani-Akollor ME, et al.: Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. Biomed. Res. Int. 2019; 2019: 4562904–4562908. PubMed Abstract | Publisher Full Text | Free Full Text
60. Strong PM, Hemkhothang LH, Brijesh Y, et al.: Overweight/obesity risks and prevalence of diabetes and hypertension in North Eastern India: An analysis using seemingly unrelated probit model. Clinical Epidemiology and Global Health. 2021; 11: 100764. 2213-3984. Publisher Full Text
61. Tan JL, Thakur K: Systolic Hypertension. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Accessed on 12^th June 2023. Reference Source
62. Petrie JR, Guzik TJ, Touyz RM: Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can. J. Cardiol. 2018; 34(5): 575–584. PubMed Abstract | Publisher Full Text | Free Full Text
63. Gaffney B, Jacobsen AP, Pallippattu AW, et al.: The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease. Integrated blood pressure control. 2021; 14: 179–187. PubMed Abstract | Publisher Full Text | Free Full Text
64. John Hopkins Medicine: Diabetes and high blood pressure. Health and Wellness Prevention.2023. Accessed on 5^th July 2023. Reference Source
65. Li X, Xu X, Liu J, et al.: HbA1c and survival in maintenance hemodialysis patients with diabetes in Han Chinese population. Int. Urol. Nephrol. 2014; 46: 2207–2214. PubMed Abstract | Publisher Full Text
66. Cheneke W, Suleman S, Yemane T, et al.: Assessment of glycemic control using glycated haemoglobin among diabetic patients in Jimma University specialized hospital, Ethiopia. BMC Dermatol. Res. 2016; 9. Publisher Full Text
67. Govender RD, Gathiram P, Panajatovic M: Poor control and management of type 2 diabetes mellitus at an under-resourced South African hospital: is it a case of clinical inertia? S. Afr. Fam. Pract. 2017; 59(5): 154–159. Publisher Full Text
68. Legese GL, Asres G, Alemu S, et al.: Determinants of poor glycemic control among type 2 diabetes mellitus patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: An unmatched case-control study. Front. Endocrinol. 2023; 14. PubMed Abstract | Publisher Full Text | Free Full Text
69. Szili-Torok T, Bakker SJL, Tietge UJF: Normal fasting triglyceride levels and incident type 2 diabetes in the general population. Cardiovasc. Diabetol. 2022; 21: 111. PubMed Abstract | Publisher Full Text | Free Full Text
70. Baqar S, Michalopoulos A, Jerums G, et al.: Dietary sodium and potassium intake in people with diabetes: are guidelines being met? Nutr. Diabetes. 2020; 10(1): 23. PubMed Abstract | Publisher Full Text | Free Full Text
71. Bower JK, Appel LJ, Matsushita K, et al.: Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study. Diabetes Care. 2012; 35(5): 1031–1037. PubMed Abstract | Publisher Full Text | Free Full Text
72. Mamo Y, Bekele F, Nigussie T, et al.: Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south-west Ethiopia: a case-control study. BMC Endocr. Disord. 2019; 19(1): 91. Publisher Full Text
73. Belew MA, Abate TW, Berhie AY, et al.: Determinants of hypertension among diabetes patients attending selected comprehensive specialized hospitals of the Amhara Region, Ethiopia: An unmatched case-control study. PLoS One. 2023; 17(12): e0279245. Publisher Full Text
74. Kannel WB: Elevated systolic blood pressure as a cardiovascular risk factor. Am. J. Cardiol. 2000; 85(2): 251–255. Publisher Full Text
75. Flint AC, Conell C, Ren X, et al.: Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes. N. Engl. J. Med. 2019; 381(3): 243–251. Publisher Full Text
76. Wheatley SD, Deakin TA, Arjomandkhah NC, et al.: Low Carbohydrate Dietary Approaches for People with Type 2 Diabetes—A Narrative Review. In Frontiers in Nutrition. 2021; 8. PubMed Abstract | Publisher Full Text | Free Full Text
77. Bonsembiante L, Targher G, Maffeis C: Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? Nutrients. 2021; 13(10): 3344. PubMed Abstract | Publisher Full Text | Free Full Text
78. Li Q, Liu C, Zhang S, et al.: Dietary Carbohydrate Intake and New-Onset Hypertension: A Nationwide Cohort Study in China. Hypertension. 2021; 78(2): 422–430. PubMed Abstract | Publisher Full Text
79. WHO: Guideline: Sodium Intake for Adults and Children. Geneva, Switzerland: World Health Organization; 2012.
80. Grillo A, Salvi L, Coruzzi P, et al.: Sodium Intake and Hypertension. Nutrients. 2019; 11(9): 1970. PubMed Abstract | Publisher Full Text | Free Full Text
81. Centres for Disease Control and Prevention: Sodium. Heart Disease.2021. Accessed on 5^th July, 2023. Reference Source
82. Menyanu E, Baatiema L, Charlton K, et al.: Towards Population Salt Reduction to Control High Blood Pressure in Ghana: A Policy Direction. Current developments in nutrition. 2020; 4(Suppl 3): nzaa084. PubMed Abstract | Publisher Full Text | Free Full Text
83. Safianu R, Plange-Rhule J: An Assessment of Usual Salt Intake among Older Normotensive Adults in Atonsu, a Suburb of Kumasi in the Ashanti Region of Ghana. Int. J. Hypertens. 2020; 2020: 1–9. Article ID 7053654. PubMed Abstract | Publisher Full Text | Free Full Text
84. Kenao TS, Sossa JC, Paraiso MN, et al.: Dietary Sodium and Potassium Intakes and Salt Reduction Strategies: Systematic Review in Africa. International Archives of Open Access Public Health and Community Medicine. 2022; 6(3). Publisher Full Text
85. Brenyah F, Apprey C, Agbenorhevi JK, et al.: Predictors of hypertension among diabetic patients in the Ejisu Municipality of Ghana. [Dataset]. Dryad. 2024. Publisher Full Text

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 21 Mar 2024

Author details Author details

¹ Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, +233, Ghana
² Department of Food Science and Technology, Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, +233, Ghana

Florence Brenyah
Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation

Charles Apprey
Roles: Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing

Jacob K. Agbenorhevi
Roles: Resources, Supervision, Writing – Review & Editing

Felix C. Mills-Robertson
Roles: Resources, Supervision, Writing – Review & Editing

Competing interests

No competing interests were disclosed.

Grant information

Kwame Nkrumah University of Science and Technology, Research Fund (KRef), Kumasi-Ghana. Grant reference number-VC/OGR/15.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Article Versions (1)

version 1

Published: 21 Mar 2024, 13:202

https://doi.org/10.12688/f1000research.146555.1

Copyright

© 2024 Brenyah F et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

0

SEE MORE DETAILS

CITE

how to cite this article

Brenyah F, Apprey C, K. Agbenorhevi J and C. Mills-Robertson F. Predictors of hypertension among diabetic patients in the Ejisu municipality of Ghana [version 1; peer review: 1 approved with reservations]. F1000Research 2024, 13:202 (https://doi.org/10.12688/f1000research.146555.1)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Version 1

VERSION 1

PUBLISHED 21 Mar 2024

Views

5

Reviewer Report 06 May 2024

Irene A Kretchy, Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana, Legon, Ghana

Approved with Reservations

https://doi.org/10.5256/f1000research.160650.r263927

Predictors of hypertension among diabetic patients in the
Ejisu municipality of Ghana
General comments
Hypertension in patients with diabetes is a major problem and this study focused on the predictors of hypertension among this population in the ... Continue reading

Predictors of hypertension among diabetic patients in the
Ejisu municipality of Ghana
General comments
Hypertension in patients with diabetes is a major problem and this study focused on the predictors of hypertension among this population in the Ejisu Municipality of Ghana. Generally, the paper is well written with some issues listed below to be addressed.

Title: Avoid the label diabetic patients. Replace with patients with diabetes. Correct this throughout the write-up

Abstract: The background should reflect the study title which is to look at the predictors of hypertension in diabetes. Issues of co-existence and comorbidity could be emphasized in the main background.
Objective: this should be rephrased as an objective with an active verb.
Methods: This should also provide information on the study design and inclusion of participants. Which factors were targeted as predictors of hypertension? These have to be specified and how they were measured also indicated
Results: provide information on the extent of hypertension and the predictors that can follow.

Introduction
The background of the study and the arguments about the extent of the problem are well-presented. It will be helpful to expand on the social gradient of health geographically concerning the occurrence of hypertension and diabetes in Ejisu. How do geographical variability due to differences in dietary behaviour, occupational status, socio-cultural
factors, environmental influences, health seeking behaviour affect diabetes and hypertension in the community.

Methods
The study setting is not well described especially to help readers who may not be familiar with the setting to appreciate the context.

What are the population sizes for the two facilities and would a proportionate distribution of the samples be better preferred?

Study variables: the background section and problem did not adequately focus on the study variables and it would be helpful to show how these variables determine hypertension in diabetes as indicated in the study title and objectives.

What language was used for data collection and how were translation and quality assured?
Results
The results section is fine. Only 18 of the participants were male. How could that be explained in terms of sampling? Were there any biases?

Discussion
Please explain why males are in the minority.
The strengths of the study should be highlighted.

Conclusion
It will be good to add the implications of the study findings.

Limitations
Other limitations related to selection and recall bias should be mentioned.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Partly
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Partly

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Social and behavioral health

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Respond or Comment

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 21 Mar 2024

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1
Version 1 21 Mar 24	read

Irene A Kretchy, University of Ghana, Legon, Ghana

Comments on this article

All Comments(0)

Add a comment

Sign up for content alerts

Browse by related subjects

Back to all reports

Reviewer Report

5 Views

06 May 2024 | for Version 1

Irene A Kretchy, Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana, Legon, Ghana

5 Views Cite this report Responses(0)

Approved With Reservations

Predictors of hypertension among diabetic patients in the
Ejisu municipality of Ghana
General comments
Hypertension in patients with diabetes is a major problem and this study focused on the predictors of hypertension among this population in the Ejisu Municipality of Ghana. Generally, the paper is well written with some issues listed below to be addressed.

Title: Avoid the label diabetic patients. Replace with patients with diabetes. Correct this throughout the write-up

Abstract: The background should reflect the study title which is to look at the predictors of hypertension in diabetes. Issues of co-existence and comorbidity could be emphasized in the main background.
Objective: this should be rephrased as an objective with an active verb.
Methods: This should also provide information on the study design and inclusion of participants. Which factors were targeted as predictors of hypertension? These have to be specified and how they were measured also indicated
Results: provide information on the extent of hypertension and the predictors that can follow.

Introduction
The background of the study and the arguments about the extent of the problem are well-presented. It will be helpful to expand on the social gradient of health geographically concerning the occurrence of hypertension and diabetes in Ejisu. How do geographical variability due to differences in dietary behaviour, occupational status, socio-cultural
factors, environmental influences, health seeking behaviour affect diabetes and hypertension in the community.

Methods
The study setting is not well described especially to help readers who may not be familiar with the setting to appreciate the context.

What are the population sizes for the two facilities and would a proportionate distribution of the samples be better preferred?

Study variables: the background section and problem did not adequately focus on the study variables and it would be helpful to show how these variables determine hypertension in diabetes as indicated in the study title and objectives.

What language was used for data collection and how were translation and quality assured?
Results
The results section is fine. Only 18 of the participants were male. How could that be explained in terms of sampling? Were there any biases?

Discussion
Please explain why males are in the minority.
The strengths of the study should be highlighted.

Conclusion
It will be good to add the implications of the study findings.

Limitations
Other limitations related to selection and recall bias should be mentioned.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Partly
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Partly

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Social and behavioral health

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Respond to this report

Responses (0)

[1] 1. Magliano DJ, Boyko EJ: IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. 10th edition.Brussels: International Diabetes Federation; 2021. Reference Source

[2] 2. Kumar A, Gangwar R, Ahmad Zargar A, et al.: Prevalence of diabetes in India: A review of IDF Diabetes Atlas 10th edition. Curr. Diabetes Rev. 2023 Apr 13; 20: e130423215752. PubMed Abstract | Publisher Full Text

[3] 3. Afaya RA, Bam V, Azongo TB, et al.: Knowledge of chronic complications of diabetes among persons living with type 2 diabetes mellitus in northern Ghana. PLos One. 2020; 15(10): e0241424. PubMed Abstract | Publisher Full Text | Free Full Text

[4] 4. World Health Organization: Diabetes 2020.July 2020. Reference Source

[5] 5. Siddiqi K: Non-communicable diseases.Walley J, Wright J, editors. Public Health: An action guide to improving health. 2nd edn.Oxford: Oxford Academic; 2010. 2010. online edn. Publisher Full Text

[6] 6. Zabetian A, Keli HM, Echouffo-Tcheugui JB, et al.: Diabetes in the middle East and north Africa. Diabetes Res. Clin. Pract. 2013; 101(2): 106–122. Publisher Full Text

[7] 7. Mehta R, Mantri N, Goel AD, et al.: Out-of-pocket spending on hypertension and diabetes among patients reporting in a health -care teaching institute of the Western Rajasthan. J. Family Med. Prim. Care. 2022; 11(3): 1083–1088. PubMed Abstract | Publisher Full Text | Free Full Text

[8] 8. Kishindo M, Kamano J, Mwangi A, et al.: Are outpatient costs for hypertension and diabetes care affordable? Evidence from Western Kenya. African Journal of Primary Health Care & Family Medicine. 2023; 15(1): e1–e9. PubMed Abstract | Publisher Full Text | Free Full Text

[9] 9. Mohan V, Seedat YK, Pradeepa R: The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int. J. Hypertens. 2013; 2013: 409083. PubMed Abstract | Publisher Full Text | Free Full Text

[10] 10. Tareque MI, Koshio A, Tiedt AD, et al.: Are the Rates of Hypertension and Diabetes Higher in People from Lower Socioeconomic Status in Bangladesh? Results from a Nationally Representative Survey. PLoS ONE. 2015; 10(5): e0127954. PubMed Abstract | Publisher Full Text | Free Full Text

[11] 11. Yaya S, El-Khatib Z, Ahinkorah BO, et al.: Prevalence and Socioeconomic Factors of Diabetes and High Blood Pressure Among Women in Kenya: A Cross-Sectional Study. Journal of epidemiology and global health. 2021; 11(4): 397–404. Publisher Full Text

[12] 12. Choukem SP, Kengne AP, Dehayem YM, et al.: Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res. Clin. Pract. 2007; 77(2): 293–299. PubMed Abstract | Publisher Full Text

[13] 13. Emmerick ICM, Campos MR, da Silva RM , et al.: Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the “Farmácia popular” program in Brazil: an interrupted time series study. BMC Public Health. 2020; 20: 24. PubMed Abstract | Publisher Full Text | Free Full Text

[14] 14. Aroda VR, Knowler WC, Crandall JP, et al.: Metformin for diabetes prevention: insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017; 60(9): 1601–1611. PubMed Abstract | Publisher Full Text | Free Full Text

[15] 15. Gatimu SM, Milimo BW, Sebastian MS: Prevalence and determinants of diabetes among older adults in Ghana. BMC Public Health. 2016; 16(1): 1174. PubMed Abstract | Publisher Full Text | Free Full Text

[16] 16. Mirzaei M, Mirzaei M, Bagheri B, et al.: Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health. 2020; 20: 667. PubMed Abstract | Publisher Full Text | Free Full Text

[17] 17. Nshisso LD, Reese A, Gelaye B, et al.: Prevalence of hypertension and diabetes among Ethiopian adults. Diabetes & metabolic syndrome. 2012; 6(1): 36–41. PubMed Abstract | Publisher Full Text | Free Full Text

[18] 18. Mariye T, Girmay A, Tasew H, et al.: Determinants of hypertension among diabetic patients in Public Hospitals of the Central Zone, Tigray, Ethiopia 2018: unmatched case-control study. Pan Afr. Med. J. 2019; 33: 100. PubMed Abstract | Publisher Full Text | Free Full Text

[19] 19. Correia JC, Lachat S, Lagger G, et al.: Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review. BMC Public Health. 2019; 19: 1542. PubMed Abstract | Publisher Full Text | Free Full Text

[20] 20. Bossman IF, Dare S, Oduro BA, et al.: Patients’ knowledge of diabetes foot complications and self-management practices in Ghana: A phenomenological study. PloS one. 2021; 16(8): e0256417. PubMed Abstract | Publisher Full Text | Free Full Text

[21] 21. Owusu AY, Kushitor SB, Ofosu AA, et al.: Institutional mortality rate and cause of death at health facilities in Ghana between 2014 and 2018. PLoS ONE. 2021; 16(9): e0256515. PubMed Abstract | Publisher Full Text | Free Full Text

[22] 22. Narh CT, Der JB, Ofosu A, et al.: Trends in hospitalization of patients with diabetes mellitus in Ghana from 2012 to predictions to 2032. Int. Health. 2022; 14(6): 588–596. PubMed Abstract | Publisher Full Text | Free Full Text

[23] 23. Awumee V, Dery SK, K.: Continuity of care among diabetic patients in Accra, Ghana. Front. Public Health. 2023; 11: 1141080. PubMed Abstract | Publisher Full Text | Free Full Text

[24] 24. Animaw W, Seyoum Y: Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 2017; 12(11): e0187670. Publisher Full Text

[25] 25. Asamoah-Boaheng M, Sarfo-Kantanka O, Tuffour AB, et al.: Prevalence and risk factors for diabetes mellitus among adults in Ghana: a systematic review and meta-analysis. Int. Health. 2019; 11(2): 83–92. PubMed Abstract | Publisher Full Text

[26] 26. Katey D, Addo AA, Abass K, et al.: Prevalence study of type 2 diabetes mellitus in the Ashanti region of Ghana: a systematic review of risk factors. J. Endocrinol. Metab. Diabetes S. Afr. 2022; 27(3): 93–99. Publisher Full Text

[27] 27. Cook-Huynh M, Ansong D, Steckelberg RC, et al.: Prevalence of hypertension and diabetes mellitus in adults from a rural community in Ghana. Ethn. Dis. 2012; 22(3): 347–352. PubMed Abstract

[28] 28. Sarfo FS, Gyamfi RA, Adamu S, et al.: Administration of a pictorial questionnaire to screen for stroke among patients with hypertension or diabetes in rural Ghana. J. Neurol. Sci. 2017; 373: 289–294. PubMed Abstract | Publisher Full Text | Free Full Text

[29] 29. Opare-Addo MN, Buabeng KO, Marfo AF, et al.: Source of medicines and medicine information by self-reported persons living with hypertension and diabetes in rural and urban Ghana. Pharmacy Practice (Granada). 2022; 16(3): 1151. Publisher Full Text

[30] 30. Haile TG, Mariye T, Tadesse DB, et al.: Prevalence of hypertension among type 2 diabetes mellitus patients in Ethiopia: a systematic review and meta-analysis. Int. Health. 2022; 15: 235–241. PubMed Abstract | Publisher Full Text | Free Full Text

[31] 31. Ghana News Association: Hypertension and diabetes on the rise in Ejisu-Juaben.2011. Accessed January 7, 2023. Reference Source

[32] 32. Obour SK: Cases of hypertension, diabetes in Ejisu alarming.2013. Accessed January 7, 2023. Reference Source

[33] 33. Owusu-Ansah J: Factors influencing treatment outcomes of Patients with Diabetes and Hypertension at the Ejisu Government Hospital in Ejisu, Ashanti Region, Ghana. Dissertation.2020. Accessed January 3, 2023. Reference Source

[34] 34. Gatorwu S: Kidney Health International hold World Diabetes Day at Ejisu.2022. Accessed May 3, 2023. Reference Source

[35] 35. Akalu Y, Belsti Y: Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia. Diabetes, metabolic syndrome and obesity: targets and therapy. 2023; 13: 1621–1631. Publisher Full Text

[36] 36. Jelinek HF, Osman WM, Khandoker AH, et al.: Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from the United Arab Emirates. BMJ Open Diabetes Research &Amp; Care. 2017; 5(1): e000427. PubMed Abstract | Publisher Full Text | Free Full Text

[37] 37. Osei-Yeboah J, Owusu-Dabo E, Owiredu WKBA, et al.: Community burden of hypertension and treatment patterns: An in-depth age predictor analysis: (The Rural Community Risk of Non-Communicable Disease Study - Nyive Phase I). PLoS One. 2021; 16(8): e0252284. PubMed Abstract | Publisher Full Text | Free Full Text

[38] 38. Swed S, Alibrahim H, Bohsas H, et al.: Assessment the awareness toward hypertension and diabetes mellitus: Syrian cross sectional study. BMC Public Health. 2023; 23: 789. PubMed Abstract | Publisher Full Text | Free Full Text

[39] 39. Noordzij M, Tripepi G, Dekker FW, et al.: Samplesize calculations: basic principles and common pitfalls. Nephrol. Dial. Transplant. 2010; 25(5): 1388–1393. PubMed Abstract | Publisher Full Text

[40] 40. Nightingale H, Walsh KJ, Olupot-Olupot P, et al.: Validation of triple pass 24-hour dietary recall in Ugandan children by simultaneous weighed food assessment. BMC Nutr. 2016; 2: 56. Publisher Full Text

[41] 41. Institutional Review Board-University of Florida: Investigator requirement for retaining research data. Protecting the right and welfare of human research subjects.2021. Accessed on 4^th July, 2023. Reference Source

[42] 42. Krishnaveni P, Gowda VM: Assessing the Validity of Friedewald’s Formula and Anandraja’s Formula For Serum LDL-Cholesterol Calculation. J. Clin. Diagn. Res. 2015; 9(12): BC01–BC04. Publisher Full Text

[43] 43. Bertakis KD, Azari R, Helms LJ, et al.: Gender differences in the utilization of health care services. J. Fam. Pract. 2000. 49(2): 147–52. PubMed Abstract

[44] 44. Hunt K, Adamson J, Hewitt C, et al.: Do women consult more than men? A review of gender and consultation for back pain and headache. J. Health Serv. Res. Policy. 2011; 16(2): 108–117. PubMed Abstract | Publisher Full Text | Free Full Text

[45] 45. Zafari N, Asgari S, Lotfaliany M, et al.: Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up. Sci. Rep. 2017; 7(1): 14220. PubMed Abstract | Publisher Full Text | Free Full Text

[46] 46. Atibila F, Owusu-Dabo E, Asamani JA, et al.: Assessment of risk factors for hypertension in Dormaa municipality in Ghana using the World Health Organization STEPS approach. J. Health Sci. 2018; 8(3): 171–180. Publisher Full Text

[47] 47. Bai A, Tao J, Tao L, et al.: Prevalence and risk factors of diabetes among adults aged 45 years or older in China: A national cross-sectional study. Endocrinology, diabetes & metabolism. 2021; 4(3): e00265. PubMed Abstract | Publisher Full Text | Free Full Text

[48] 48. Ramezankhani A, Azizi F, Hadaegh F: Associations of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: A long-term follow-up study. PLoS One. 2019; 14(4): e0215593. PubMed Abstract | Publisher Full Text | Free Full Text

[49] 49. Tuoyire D, Ayetey H: Gender difference in the association between marital status and hypertension in Ghana. J. Biosoc. Sci. 2019; 51(3): 313–334. Publisher Full Text

[50] 50. Ford KJ, Robitaille A: How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing. BMJ Open Diabetes Research & Care. 2023; 11(1): e003080. PubMed Abstract | Publisher Full Text | Free Full Text

[51] 51. Tedesco MA, Di Salvo G, Caputo S, et al.: Educational level and hypertension: how socioeconomic differences condition health care. J. Hum. Hypertens. 2021; 15: 727–731. PubMed Abstract | Publisher Full Text

[52] 52. Sun K, Lin D, Li M, et al.: Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adults. J. Epidemiol. Community Health. 2022; 76: 451–457. PubMed Abstract | Publisher Full Text | Free Full Text

[53] 53. Cederberg H, Stančáková A, Kuusisto J, et al.: A family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage?. J. Intern. Med. 2015; 277(5): 540–551. PubMed Abstract | Publisher Full Text

[54] 54. Dosoo DK, Nyame S, Enuameh Y, et al.: Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study. Int. J. Hypertens. 2019; 2019: 1–7. Publisher Full Text

[55] 55. Li AL, Peng Q, Shao YQ, et al.: The interaction on hypertension between family history and diabetes and other risk factors. Sci. Rep. 2021; 11(1): 4716. PubMed Abstract | Publisher Full Text | Free Full Text

[56] 56. Berbari AE, Daouk NA, Nasr EM: Coexistence of Diabetes Mellitus and Hypertension.Berbari AE, Mancia G, editors. Blood Pressure Disorders in Diabetes Mellitus. Updates in Hypertension and Cardiovascular Protection. Cham: Springer; 2023. Publisher Full Text

[57] 57. Patel SA, Ali MK, Alam D, et al.: Obesity and its Relation with Diabetes and Hypertension: A Cross-Sectional Study Across 4 Geographical Regions. Glob. Heart. 2016; 11(1): 71–79.e4. PubMed Abstract | Publisher Full Text | Free Full Text

[58] 58. Ofori-Asenso R, Agyeman AA, Laar A, et al.: Overweight and obesity epidemic in Ghana-a systematic review and meta-analysis. BMC Public Health. 2016; 16(1): 1239. PubMed Abstract | Publisher Full Text | Free Full Text

[59] 59. Agyemang-Yeboah F, Eghan BAJ, Annani-Akollor ME, et al.: Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. Biomed. Res. Int. 2019; 2019: 4562904–4562908. PubMed Abstract | Publisher Full Text | Free Full Text

[60] 60. Strong PM, Hemkhothang LH, Brijesh Y, et al.: Overweight/obesity risks and prevalence of diabetes and hypertension in North Eastern India: An analysis using seemingly unrelated probit model. Clinical Epidemiology and Global Health. 2021; 11: 100764. 2213-3984. Publisher Full Text

[61] 61. Tan JL, Thakur K: Systolic Hypertension. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Accessed on 12^th June 2023. Reference Source

[62] 62. Petrie JR, Guzik TJ, Touyz RM: Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can. J. Cardiol. 2018; 34(5): 575–584. PubMed Abstract | Publisher Full Text | Free Full Text

[63] 63. Gaffney B, Jacobsen AP, Pallippattu AW, et al.: The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease. Integrated blood pressure control. 2021; 14: 179–187. PubMed Abstract | Publisher Full Text | Free Full Text

[64] 64. John Hopkins Medicine: Diabetes and high blood pressure. Health and Wellness Prevention.2023. Accessed on 5^th July 2023. Reference Source

[65] 65. Li X, Xu X, Liu J, et al.: HbA1c and survival in maintenance hemodialysis patients with diabetes in Han Chinese population. Int. Urol. Nephrol. 2014; 46: 2207–2214. PubMed Abstract | Publisher Full Text

[66] 66. Cheneke W, Suleman S, Yemane T, et al.: Assessment of glycemic control using glycated haemoglobin among diabetic patients in Jimma University specialized hospital, Ethiopia. BMC Dermatol. Res. 2016; 9. Publisher Full Text

[67] 67. Govender RD, Gathiram P, Panajatovic M: Poor control and management of type 2 diabetes mellitus at an under-resourced South African hospital: is it a case of clinical inertia? S. Afr. Fam. Pract. 2017; 59(5): 154–159. Publisher Full Text

[68] 68. Legese GL, Asres G, Alemu S, et al.: Determinants of poor glycemic control among type 2 diabetes mellitus patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: An unmatched case-control study. Front. Endocrinol. 2023; 14. PubMed Abstract | Publisher Full Text | Free Full Text

[69] 69. Szili-Torok T, Bakker SJL, Tietge UJF: Normal fasting triglyceride levels and incident type 2 diabetes in the general population. Cardiovasc. Diabetol. 2022; 21: 111. PubMed Abstract | Publisher Full Text | Free Full Text

[70] 70. Baqar S, Michalopoulos A, Jerums G, et al.: Dietary sodium and potassium intake in people with diabetes: are guidelines being met? Nutr. Diabetes. 2020; 10(1): 23. PubMed Abstract | Publisher Full Text | Free Full Text

[71] 71. Bower JK, Appel LJ, Matsushita K, et al.: Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study. Diabetes Care. 2012; 35(5): 1031–1037. PubMed Abstract | Publisher Full Text | Free Full Text

[72] 72. Mamo Y, Bekele F, Nigussie T, et al.: Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south-west Ethiopia: a case-control study. BMC Endocr. Disord. 2019; 19(1): 91. Publisher Full Text

[73] 73. Belew MA, Abate TW, Berhie AY, et al.: Determinants of hypertension among diabetes patients attending selected comprehensive specialized hospitals of the Amhara Region, Ethiopia: An unmatched case-control study. PLoS One. 2023; 17(12): e0279245. Publisher Full Text

[74] 74. Kannel WB: Elevated systolic blood pressure as a cardiovascular risk factor. Am. J. Cardiol. 2000; 85(2): 251–255. Publisher Full Text

[75] 75. Flint AC, Conell C, Ren X, et al.: Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes. N. Engl. J. Med. 2019; 381(3): 243–251. Publisher Full Text

[76] 76. Wheatley SD, Deakin TA, Arjomandkhah NC, et al.: Low Carbohydrate Dietary Approaches for People with Type 2 Diabetes—A Narrative Review. In Frontiers in Nutrition. 2021; 8. PubMed Abstract | Publisher Full Text | Free Full Text

[77] 77. Bonsembiante L, Targher G, Maffeis C: Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? Nutrients. 2021; 13(10): 3344. PubMed Abstract | Publisher Full Text | Free Full Text

[78] 78. Li Q, Liu C, Zhang S, et al.: Dietary Carbohydrate Intake and New-Onset Hypertension: A Nationwide Cohort Study in China. Hypertension. 2021; 78(2): 422–430. PubMed Abstract | Publisher Full Text

[79] 79. WHO: Guideline: Sodium Intake for Adults and Children. Geneva, Switzerland: World Health Organization; 2012.

[80] 80. Grillo A, Salvi L, Coruzzi P, et al.: Sodium Intake and Hypertension. Nutrients. 2019; 11(9): 1970. PubMed Abstract | Publisher Full Text | Free Full Text

[81] 81. Centres for Disease Control and Prevention: Sodium. Heart Disease.2021. Accessed on 5^th July, 2023. Reference Source

[82] 82. Menyanu E, Baatiema L, Charlton K, et al.: Towards Population Salt Reduction to Control High Blood Pressure in Ghana: A Policy Direction. Current developments in nutrition. 2020; 4(Suppl 3): nzaa084. PubMed Abstract | Publisher Full Text | Free Full Text

[83] 83. Safianu R, Plange-Rhule J: An Assessment of Usual Salt Intake among Older Normotensive Adults in Atonsu, a Suburb of Kumasi in the Ashanti Region of Ghana. Int. J. Hypertens. 2020; 2020: 1–9. Article ID 7053654. PubMed Abstract | Publisher Full Text | Free Full Text

[84] 84. Kenao TS, Sossa JC, Paraiso MN, et al.: Dietary Sodium and Potassium Intakes and Salt Reduction Strategies: Systematic Review in Africa. International Archives of Open Access Public Health and Community Medicine. 2022; 6(3). Publisher Full Text

[85] 85. Brenyah F, Apprey C, Agbenorhevi JK, et al.: Predictors of hypertension among diabetic patients in the Ejisu Municipality of Ghana. [Dataset]. Dryad. 2024. Publisher Full Text

Predictors of hypertension among diabetic patients in the Ejisu municipality of Ghana

Abstract

Introduction

Objective

Methods

Results

Conclusion

Keywords

Introduction

Methods

Study setting

Study type and approach

Study population

Sample selection technique

Inclusion and exclusion criteria

Sample size determination

Data collection tools and administration

Study variables

Data management

Data analysis

Results

Socio-demographic characteristics of participants

Table 1. Socio-demographic characteristics of participants.

Medical history of non-communicable diseases

Table 2. Family medical history of NCDs.

Anthropometrics and blood pressure parameters of respondents

Table 3. Anthropometric and blood pressure parameters of respondents.

Biochemical parameters of respondents

Table 4. Biochemical parameters of respondents.

Dietary intakes of respondents

Table 5. Dietary intakes of participants.

Hypertension among diabetic patients

Table 6. Hypertension among diabetic patients.

Predictors of hypertension among diabetic patients

Table 7. Predictors of hypertension among diabetic patients.

Discussion

Conclusion

Study limitation

Recommendations

Direction for future research

Data availability

Underlying data

Extended data

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated